Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Masternak

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Molecules (Basel, Switzerland)|January 31, 2019
Vitamin C as a Modulator of the Response to Cancer TherapyWiktoria Blaszczak, Wojciech Barczak, Julia Masternak, et al.
Frontiers in Pharmacology|September 12, 2022
Combined hyperforin and lanicemine treatment instead of ketamine or imipramine restores behavioral deficits induced by chronic restraint stress and dietary zinc restriction in miceBartłomiej Pochwat, Paulina Misztak, Julia Masternak, et al.
Acta Pharmacologica Sinica|February 3, 2026
Chronic 5-HT7R activation drives depressive phenotypes and synaptic dysfunctionBartłomiej Pochwat, Julia Masternak, Bartosz Bobula, et al.
Cell Reports|March 16, 2022
Activation of the 5-HT7 receptor and MMP-9 signaling module in the hippocampal CA1 region is necessary for the development of depressive-like behaviorMonika Bijata, Ewa Bączyńska, Franziska E Müller, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Molecules (Basel, Switzerland)|January 31, 2019
Vitamin C as a Modulator of the Response to Cancer TherapyWiktoria Blaszczak, Wojciech Barczak, Julia Masternak, et al.
Frontiers in Pharmacology|September 12, 2022
Combined hyperforin and lanicemine treatment instead of ketamine or imipramine restores behavioral deficits induced by chronic restraint stress and dietary zinc restriction in miceBartłomiej Pochwat, Paulina Misztak, Julia Masternak, et al.
Acta Pharmacologica Sinica|February 3, 2026
Chronic 5-HT7R activation drives depressive phenotypes and synaptic dysfunctionBartłomiej Pochwat, Julia Masternak, Bartosz Bobula, et al.
Cell Reports|March 16, 2022
Activation of the 5-HT7 receptor and MMP-9 signaling module in the hippocampal CA1 region is necessary for the development of depressive-like behaviorMonika Bijata, Ewa Bączyńska, Franziska E Müller, et al.
Pageof 1